ISDA

Deposition Date 2022-06-20

Release Date 2022-12-14

Last Version Date 2024-04-03

Entry Detail

PDB ID:

8DEG

Keywords:

SIGNALING PROTEIN,TRANSFERASE/INHIBITOR

Title:

Crystal structure of DLK in complex with inhibitor DN0011197

Biological Source:

Source Organism:

Homo sapiens (Taxon ID: 9606)

Host Organism:

Spodoptera frugiperda

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

2.79 Å

R-Value Free:

0.29

R-Value Work:

0.24

R-Value Observed:

0.25

Space Group:

P 1 21 1

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Molecule:Mitogen-activated protein kinase kinase kinase 12
Gene (Uniprot):MAP3K12
Chain IDs:A
Chain Length:322
Number of Molecules:1
Biological Source:Homo sapiens

UniProt ID:Q12852 Pfam ID:PF07714

Ligand Molecules

SIQ

Primary Citation

Discovery of Potent and Selective Dual Leucine Zipper Kinase/Leucine Zipper-Bearing Kinase Inhibitors with Neuroprotective Properties in In Vitro and In Vivo Models of Amyotrophic Lateral Sclerosis.

Craig 2nd, R.A, Fox, B.M, Hu, C, Lexa, K.W, Osipov, M, Thottumkara, A.P, Larhammar, M, Miyamoto, T, Rana, A, Kane, L.A, Yulyaningsih, E, Solanoy, H, Nguyen, H, Chau, R, Earr, T, Kajiwara, Y, Fleck, D, Lucas, A, Haddick, P.C.G, Takahashi, R.H, Tong, V, Wang, J, Canet, M.J, Poda, S.B, Scearce-Levie, K, Srivastava, A, Sweeney, Z.K, Xu, M, Zhang, R, He, J, Lei, Y, Zhuo, Z, de Vicente, J.Show

J.Med.Chem. 65 16290 16312 (2022)

PMID: 36469401 DOI: 10.1021/acs.jmedchem.2c01056

Abstact

Dual leucine zipper kinase (DLK) and leucine zipper-bearing kinase (LZK) are regulators of neuronal degeneration and axon growth. Therefore, there is a considerable interest in developing DLK/LZK inhibitors for neurodegenerative diseases. Herein, we use ligand- and structure-based drug design approaches for identifying novel amino-pyrazine inhibitors of DLK/LZK. DN-1289 (14), a potent and selective dual DLK/LZK inhibitor, demonstrated excellent in vivo plasma half-life across species and is anticipated to freely penetrate the central nervous system with no brain impairment based on in vivo rodent pharmacokinetic studies and human in vitro transporter data. Proximal target engagement and disease relevant pathway biomarkers were also favorably regulated in an in vivo model of amyotrophic lateral sclerosis.

Legend

Protein

Chemical

Disease

Primary Citation of related structures